Hodgkin Lymphoma in Adolescent and Young Adults: Real-World Data from a Single Tertiary Cancer Center in India-Reference-Cited by-同舟云学术

Hodgkin Lymphoma in Adolescent and Young Adults: Real-World Data from a Single Tertiary Cancer Center in India

Published:2020-10-22 Issue: Volume: Page:
ISSN:2156-5333
Container-title:Journal of Adolescent and Young Adult Oncology
language:en
Short-container-title:Journal of Adolescent and Young Adult Oncology

Author:

Nayak Lingaraj¹,Jain Hasmukh¹,Bonda Avinash¹,Epari Sridhar²,Laskar Siddhartha³,Gokarn Anant¹,Shet Tanuja²,Gujral Sumeet²,Khanna Nehal³,Bagal Bhausaheb¹,Punatar Sachin¹,Goda Jayant³,Thorat Jayashree¹,Rengaraj Karthik¹,Sengar Manju¹

Affiliation:

1. Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.

2. Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.

3. Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.

Publisher

Mary Ann Liebert Inc

Subject

Oncology,Pediatrics, Perinatology, and Child Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/jayao.2020.0061

Reference15 articles.

1. Chronic Health Conditions in Adult Survivors of Childhood Cancer

2. Revised Response Criteria for Malignant Lymphoma

3. Adolescent Hodgkin Lymphoma

4. Procarbazine-Free OEPA-COPDAC Chemotherapy in Boys and Standard OPPA-COPP in Girls Have Comparable Effectiveness in Pediatric Hodgkin's Lymphoma: The GPOH-HD-2002 Study

5. A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Azilsartan as a preventive agent against cyclophosphamide-induced testicular injury in male rats;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-02

2. Clinical Profile and Outcome of Adult Classical Hodgkin’s Lymphoma: Real World Single Centre Experience;Indian Journal of Hematology and Blood Transfusion;2024-02-09

3. Long-term clinical outcomes of combined modality therapy for advanced-stage Hodgkin lymphoma in the PET era: A retrospective study;Indian Journal of Medical Research;2024

4. Dacarbazine/doxorubicin/vinblastine;Reactions Weekly;2022-04